<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73968">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02025543</url>
  </required_header>
  <id_info>
    <org_study_id>2013-1174</org_study_id>
    <nct_id>NCT02025543</nct_id>
  </id_info>
  <brief_title>Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content</brief_title>
  <official_title>Confounder-Corrected Quantitative Magnetic Resonance Imaging (MRI) Biomarker of Hepatic Iron Content</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multi-site research is to validate a rapid magnetic resonance based
      confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron
      concentrations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Primary Outcome Measure</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>We expect to demonstrate equivalence between R2 measured with different protocols with higher repeatability than standard MRI iron imaging measurement and with linear calibration to liver iron concentration . This project will be considered a success if we establish the reproducibility of confounder-corrected R2 MRI: we expect the calibrations at all sites to be equivalent.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Precision Outcome Measure</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Repeat scans will be used at each site to determine precision of R2 liver iron concentration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy Outcome Measure</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>In addition to correlation with liver iron concentration (technical accuracy), the diagnostic accuracy through receiver operator characteristic curve analysis will also be determined.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Robustness Outcome Measure</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>At each site and field strength, R2* measurements from the eight different protocols will be compared to assess robustness.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Iron Overload</condition>
  <condition>Hemochromatosis</condition>
  <condition>Hemosiderosis</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <description>Subjects with known or suspected iron overload</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Subjects with no known history of iron overload or liver disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>R2 MRI scan</description>
    <arm_group_label>Patient</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>Magnetic Resonance Imaging</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with known or suspected iron overload
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  know or suspected iron overload

        Exclusion Criteria:

          -  contraindication to magnetic resonance imaging
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Wisconsin, Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Yakey, RN</last_name>
      <phone>608-265-3018</phone>
      <email>jyakey@uwhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Deborah Gawin, RN</last_name>
      <phone>608-265-8580</phone>
      <email>dgawin@uwhealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Scott Reeder, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 27, 2013</lastchanged_date>
  <firstreceived_date>December 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MRI</keyword>
  <keyword>Iron overload</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemochromatosis</mesh_term>
    <mesh_term>Hemosiderosis</mesh_term>
    <mesh_term>Iron Overload</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
